Clinical Trial Update: Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating aerosolized amphotericin B liposomal (Ambisome) in combination with itraconazole for chronic pulmonary aspergillosis is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Aspergillosis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)
• Itraconazole (Itraconazole)

Snippet

Sponsor: Poitiers University Hospital | Conditions: Chronic Pulmonary Aspergillosis | Phase 3 | Status: RECRUITING